[1] 毕旭明. 瑞舒伐他汀联合曲美他嗪对冠心病的疗效[J].中华心脏与心律电子杂志,2019,7(4):214-2166. [2] 王振,徐通达,李东野. 冠心病合并糖尿病经皮冠状动脉介入治疗术后支架内再狭窄预测因素分析[J].安徽医药,2019,23(9):1821-1825. [3] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67. [4] Lefèvre T,Haude M,Neumann FJ,et al.Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: 5-year outcomes of the randomized BIOFLOW-II Trial[J]. JACC Cardiovasc Interv,2018,11(10):995-1002. [5] 管考华,杨巍,刘世诺,等. 药物涂层球囊在冠状动脉介入治疗中的应用[J].中国老年学杂志,2017,37(5):1297-1300. [6] Zbinden R,von Felten S,Wein B,et al. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and healtheconomic evaluation[J]. Cardiovasc Ther,2017,35(1):19-25. [7] Alraies MC,Darmoch F,Tummala R,et al. Diagnosis and management challenges of in-stent restenosis in coronary arteries[J]. World JCardiol,2017,9(8):640-651. [8] 陶丹丹. 冠心病合并糖尿病患者经皮冠状动脉介入治疗中的支架选择的研究[J].中国医疗器械信息,2019,25(9):108-109. [9] 田乃亮,叶飞,张俊杰,等. 冠状动脉造影和血管内超声引导药物洗脱支架植入治疗冠状动脉慢性闭塞病变远期效果的对比研究[J].临床心血管病杂志,2016,32(5):459-463. [10] Bavishi C,Sardar P,Chatterjee S,et al.Intravascular ultrasound-guidedvs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials[J]. Am HeartJ,2017,185(3):26-34. [11] 梁利平,朴哲浩,林小叶,等. 光学相干断层成像和血管内超声在PCI术中的应用比较[J]. 中国实验诊断学,2018,22(12):2206-2207. [12] 徐占领.冠状动脉血管内超声检查对冠心病冠脉支架置入术的应用价值[J].安徽医药,2019,23(4):665-668. |